US2005095232A1PendingUtilityA1
Vaginal care composition
Priority: Nov 3, 2003Filed: Oct 29, 2004Published: May 5, 2005
Est. expiryNov 3, 2023(expired)· nominal 20-yr term from priority
Inventors:Peter-Hansen Volkmann
A61P 31/10A61P 31/12A61P 31/04A61P 15/02A61P 15/00A61K 36/064A61K 8/99A61K 35/747A61K 35/745A61K 33/30A61K 36/61A61K 8/671A61K 9/0036A61K 8/27A61Q 15/00A61K 8/9728A61K 31/07A61K 36/28A61K 36/53A61K 9/0034A61K 35/74A61K 33/04
44
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A vaginal care composition which is introduced directly into the vagina in the form of an ovule, a cream or an ointment or with a tampon or which is brought into a position outside the vagina on a panty liner. The composition comprises viable Lactobacillus or Bifidobacterium microorganisms, non-viable Saccharomyces cultures, saccharide(s); vitamin A/retinol, and zinc.
Claims
exact text as granted — not AI-modified1 . Vaginal care composition, comprising viable Lactobacillus or Bifidobacterium microorganisms, non-viable Saccharomyces cultures, saccharide(s); vitamin A/retinol, and zinc.
2 . The vaginal care composition according to claim 1 , wherein the Lactobacillus microorganism comprises Lactobacillus bifidus.
3 . The vaginal care composition according to claim 1 , wherein the non-viable Saccharomyces culture comprises Saccharomyces cerevisiae
4 . Vaginal care composition according to claim 1 , further comprising comprises selenium,
5 . Vaginal care composition according to claim 1 , wherein the selenium comprises selenium-containing yeast, in an amount of from 0.001 to 0.06 wt. % selenium.
6 . Vaginal care composition according to claim 1 , further comprising Melaleuca aetheroleum or camomile flower extract.
7 . Vaginal care composition according to claim 1 , additionally comprising D-alpha-tocopherol or pantothenate.
8 . Vaginal care composition according to claim 1 , additionally comprising fragrances.
9 . Vaginal care composition according to claim 8 , wherein the fragrance comprises lavender oil in an amount of from 0.5 to 10 wt. %.
10 . Vaginal care composition according to claim 1 , further comprising cocoa butter or a hard-fat carrier as base.
11 . Vaginal care composition according to claim 1 , wherein the composition comprises the constituents in the following amounts:
Lactobacillus/Bifidobacterium : from 10 7 to 10 10 microorganisms/g of composition, 5% Saccharomyces : from 0.1 to 40 wt. % saccharide(s): from 1 to 40 wt. % vitamin A: from 0.01 to 0.5 wt. % zinc: from 0.2 to 10 wt. %.
12 . Vaginal care composition according to claim 1 , wherein the saccharide is selected from: oligofructose, inulin or lactose.
13 . Vaginal care composition according to claim 1 , wherein the zinc is in the form of zinc sulfate or zinc gluconate.
14 . Vaginal care composition according to claim 1 , wherein the vitamin A is in the form of retinyl acetate or retinyl gluconate.
15 . Method of caring for the vaginal mucosa and for preventing infections thereof by bacteria, fungi and/or viruses, comprising administering an effective amount of a composition comprising viable Lactobacillus or Bifidobacterium microorganisms, non-viable Saccharomyces cultures, saccharide(s); vitamin A/retinol, and zinc.
16 . The method according to claim 11 , wherein the composition is applied directly to the vaginal mucosa.
17 . An ovule, comprising a composition comprising viable Lactobacillus or Bifidobacterium microorganisms, non-viable Saccharomyces cultures, saccharide(s); vitamin A/retinol, and zinc.
18 . Ovule according to claim 17 , having a weight of 3 g per ovule, comprising per gram:
from 10 7 to 10 9 , Lactobacillus bifidus microorganisms/g, 5%, from 1 to 10 wt. % Saccharomyces cerevisiae, from 0.05 to 0.3 wt. % vitamin A, from 1 to 3 wt. % D-alpha-tocopherol, from 0.4 to 1.5 wt. % pantothenate, from 0.5 to 5 wt. % zinc, from 0.002 to 0.02 wt. % selenium, from 1 to 5 wt. % Melaleuca aetheroleum, from 1 to 5 wt. % lavender oil, from 0.2 to 3 wt. % camomile flower oil extract and/or from 2 to 20 wt. % oligofructose.
19 . Ovule according to claim 17 , wherein the ovule is composed of coconut oil, glycerol-gelatin or polyethylene glycol.
20 . Ovule according to claim 17 , wherein the ovule further comprises cocoa butter or hard fats.
21 . Care cream comprising composition comprising viable Lactobacillus or Bifidobacterium microorganisms, non-viable Saccharomyces cultures, saccharide(s); vitamin A/retinol, and zinc
22 . Care cream according to claim 21 , comprising
from 10 7 to 10 9 Lactobacillus bifidus microorganisms/g, 5%, from 1 to 10 wt. %, Saccharomyces cerevisiae, from 0.05 to 0.3 wt. % vitamin A, from 1 to 3 wt. % D-alpha-tocopherol, from 0.4 to 1.5 wt. % pantothenate, from 1 to 6 wt. % zinc, from 1 to 5 wt. % Melaleuca aetheroleum, from 0.05 to 3 wt. % camomile flower extract, from 2 to 20 wt. % oligofructose or from 1 to 5 wt. %, lavender oil.
23 . Care cream according to claim 22 , wherein the cream further comprises constituents selected from the following group: sunflower oil, Tegomuls 90 S, cetyl alcohol, Cetaceum artificiale, Polysorbat 80, methyl 4-hydroxybenzoate, propyl 4-hydroxybenzoate, sesame oil, wool wax, yellow wax, wool wax alcohols, glycerol, glycerol esters, palmitic acid ester, white Vaseline, liquid wax, olive oil and distilled water.
24 . Vaginal tampon comprising the vaginal care composition comprising viable Lactobacillus or Bifidobacterium microorganisms, non-viable Saccharomyces cultures, saccharide(s); vitamin A/retinol, and zinc.
25 . Vaginal tampon according to claim 20 , comprising from 2 to 4 g, of the vaginal care composition per tampon, comprising per gram of the composition:
from 10 7 to 10 9 Lactobacillus bifidus microorganisms/g, 5%, from 1 to 10 wt. %, Saccharomyces cerevisiae, from 0.05 to 0.3 wt. % retinol acetate, from 1 to 3 wt. %, D-alpha-tocopherol, from 1 to 6 wt. % zinc, from 1 to 5 wt. % Melaleuca aetheroleum or from 2 to 20 wt. % oligofructose.
26 . Vaginal tampon according to claim 24 , comprising a liquid-repellent outer layer and an inner, storage layer.
27 . Vaginal tampon according to claim 24 , wherein the vaginal care composition is applied to a superficial layer of the tampon by spraying or immersing processes or the composition penetrates the entire tampon.
28 . Vaginal tampon according to claim 24 , wherein the vaginal care composition is contained solely in a layer directly beneath an outer cover layer of the tampon.
29 . Vaginal tampon according to claim 24 , wherein the vaginal care composition is activated by moisture.
30 . A panty liner, comprising a vaginal care composition comprising viable Lactobacillus or Bifidobacterium microorganisms, non-viable Saccharomyces cultures, saccharide(s); vitamin A/retinol, and zinc.
31 . Panty liner according to claim 30 , comprising from 2 to 5 g of the vaginal care composition per panty liner, 1 g of the composition comprising:
from 10 7 to 10 9 Lactobacillus bifidus microorganisms/g, 5%, from 1 to 10 wt. % Saccharomyces cerevisiae, from 0.05 to 0.3 wt. % retinol acetate, from 1 to 3 wt. % D-alpha-tocopherol, from 1 to 6 wt. % zinc and/or from 2 to 20 wt. % oligofructose.
32 . Panty liner according to claim 30 , further comprising a cover layer, a liquid-repelling layer, a storage layer and a backing layer.
33 . Panty liner according to claim 30 , wherein the vaginal care composition is applied to an upper layer by a spraying process or one or more further layers are provided therewith.
34 . Panty liner according to claim 30 , wherein the vaginal care composition is contained solely in a layer directly beneath the cover layer of the panty liner.
35 . Panty liner according to claim 1 , wherein the vaginal care composition is activated by moisture.Join the waitlist — get patent alerts
Track US2005095232A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.